Dr. Emmanuelle Pourcher, MD,Msc,DEM,FRCP(C) - Facuty of Medicine,Laval University - Neurologist/Neuropsychiatrist

Dr. Emmanuelle Pourcher

MD,Msc,DEM,FRCP(C)

Facuty of Medicine,Laval University

Neurologist/Neuropsychiatrist

Quebec, Quebec | Canada

Main Specialties: Neurology

Additional Specialties: Movement Disorders/Neuropsychiatry

Dr. Emmanuelle Pourcher, MD,Msc,DEM,FRCP(C) - Facuty of Medicine,Laval University - Neurologist/Neuropsychiatrist

Dr. Emmanuelle Pourcher

MD,Msc,DEM,FRCP(C)

Introduction

Primary Affiliation: Facuty of Medicine,Laval University - Quebec, Quebec , Canada

Specialties:

Additional Specialties:

Publications

36Publications

872Reads

7Profile Views

250PubMed Central Citations

Adenosine A2 receptor antagonists for the treatment of motor symptoms in Parkinson's disease.

MDCP;5(1)131-141

Movement Disorders Clinical Practice

View Article
July 2015
13 Reads

Paul J. Bédard:MD,PhD:January 19,1942-December 26,2014

Prog NeuroBioPsy;60(1):132-133

Progress in Neuropsychopharmacology and Biological Psychiatry

View Article
June 2015
10 Reads

In memoriam:Paul J.Bédarrd:January 19,1942-December 26,2014

MDS;30(3):299-300

Movement Disorders

View Article
March 2015
14 Reads

Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.

Clin Neuropharmacol 2014 Jan-Feb;37(1):9-16

*Department of Neurology, Behavioural Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; †Department of Neurology, Medical University Innsbruck, Innsbruck, Austria; ‡Middelheim Hospital, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; §Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; ║Neurodegenerative Diseases Centre, Department of Medicine, University of Salerno, Italy; ¶Department of Neurology, Movement Disorders Unit, Hospital de Sant Pau (IIB-Sant Pau) and CIBERNED, Universitat Autònoma de Barcelona, Barcelona, Spain; #Québec Memory and Motor Skills Disorders Research Center, Clinique Sainte Anne, Québec, Canada; **Division of Neurodegenerative Diseases, Department of Neurology, Dresden University of Technology, Dresden, Germany; ††Department of Neurology, Hospital de Clinicas, University of Buenos Aires, Argentina; ‡‡Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom; §§Service De Neurologie CHU, Clermont-Ferrand, France; ║║Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center, Kansas City, KS; ¶¶Novartis Pharma AG, Basel, Switzerland; and ##Novartis Pharmaceuticals Corporation, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/clinicalneuropharm/2014/01000/L
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/WNF.0000000000000010DOI Listing
September 2014
23 Reads
6 Citations
1.840 Impact Factor

Donepezil and Selegeline to improve balance control in Early Progressive Supranuclear Palsy.

J Neurol Dis; 2(3):1-4

Journal of Neurological Disorders

View Article
July 2014
15 Reads

Dopaminergic innervation of the human subventricular zone : a comparison between Huntington's chorea and Parkinson's disease.

Am J Neurodeg Dis;2(3)221-227

American Journal of Neurodegenerative Disorders

View Article
June 2014
11 Reads

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Authors:
M Flint Beal David Oakes Ira Shoulson Claire Henchcliffe Wendy R Galpern Richard Haas Jorge L Juncos John G Nutt Tiffini Smith Voss Bernard Ravina Clifford M Shults Karen Helles Victoria Snively Mark F Lew Brian Griebner Arthur Watts Shan Gao Emmanuelle Pourcher Louisette Bond Katie Kompoliti Pinky Agarwal Cherissa Sia Mandar Jog Linda Cole Munira Sultana Roger Kurlan Irene Richard Cheryl Deeley Cheryl H Waters Angel Figueroa Ani Arkun Matthew Brodsky William G Ondo Christine B Hunter Joohi Jimenez-Shahed Alicia Palao Janis M Miyasaki Julie So James Tetrud Liza Reys Katharine Smith Carlos Singer Anita Blenke David S Russell Candace Cotto Joseph H Friedman Margaret Lannon Lin Zhang Edward Drasby Rajeev Kumar Thyagarajan Subramanian Donna Stuppy Ford David A Grimes Diane Cote Jennifer Conway Andrew D Siderowf Marian Leslie Evatt Barbara Sommerfeld Abraham N Lieberman Michael S Okun Ramon L Rodriguez Stacy Merritt Camille Louise Swartz W R Wayne Martin Pamela King Natividad Stover Stephanie Guthrie Ray L Watts Anwar Ahmed Hubert H Fernandez Adrienna Winters Zoltan Mari Ted M Dawson Becky Dunlop Andrew S Feigin Barbara Shannon Melissa Jill Nirenberg Mattson Ogg Samuel A Ellias Cathi-Ann Thomas Karen Frei Ivan Bodis-Wollner Sofya Glazman Thomas Mayer Robert A Hauser Rajesh Pahwa April Langhammer Ranjit Ranawaya Lorelei Derwent Kapil D Sethi Buff Farrow Rajan Prakash Irene Litvan Annette Robinson Alok Sahay Maureen Gartner Vanessa K Hinson Samuel Markind Melisa Pelikan Joel S Perlmutter Johanna Hartlein Eric Molho Sharon Evans Charles H Adler Amy Duffy Marlene Lind Lawrence Elmer Kathy Davis Julia Spears Stephanie Wilson Maureen A Leehey Neal Hermanowicz Shari Niswonger Holly A Shill Sanja Obradov Alex Rajput Marilyn Cowper Stephanie Lessig David Song Deborah Fontaine Cindy Zadikoff Karen Williams Karen A Blindauer Jo Bergholte Clara Schindler Propsom Mark A Stacy Joanne Field Dragos Mihaila Mark Chilton Ergun Y Uc Jeri Sieren David K Simon Lauren Kraics Althea Silver James T Boyd Robert W Hamill Christopher Ingvoldstad Jennifer Young Karen Thomas Sandra K Kostyk Joanne Wojcieszek Ronald F Pfeiffer Michel Panisset Monica Beland Stephen G Reich Michelle Cines Nancy Zappala Jean Rivest Richard Zweig L Pepper Lumina Colette Lynn Hilliard Stephen Grill Marye Kellermann Paul Tuite Susan Rolandelli Un Jung Kang Joan Young Jayaraman Rao Maureen M Cook Lawrence Severt Karyn Boyar

JAMA Neurol 2014 May;71(5):543-52

Department of Neurology, Beth Israel Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.131DOI Listing
May 2014
127 Reads
40 Citations

Effects of 24 wk of treadmill training on gait performance in Parkinson's disease.

Med Sci Sports Exerc 2014 Apr;46(4):645-55

1Department of Kinesiology, Laval University, Quebec City, QC, CANADA; 2Centre d'excellence sur le vieillissement de Québec, Centre de recherche du CHU de Québec, Quebec City, QC, CANADA; 3Quebec Memory and Motor Skills Disorders Research Center, Clinique Sainte-Anne, Quebec City, QC, CANADA; and 4Department of medicine, Laval University, Quebec City, QC, CANADA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000000144DOI Listing
April 2014
57 Reads
8 Citations
3.983 Impact Factor

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.

Parkinsonism Relat Disord 2014 Feb 5;20(2):142-8. Epub 2013 Sep 5.

Impax Pharmaceuticals, Hayward, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2013.08.017DOI Listing
February 2014
46 Reads
19 Citations
3.972 Impact Factor

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.

Mov Disord 2013 Jun 15;28(6):817-20. Epub 2013 Apr 15.

Emory University School of Medicine, Department of Neurology, Atlanta, Georgia 30329, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25395DOI Listing
June 2013
30 Reads
10 Citations
5.680 Impact Factor

Investigation of C9orf72 repeat expansions in Parkinson's disease.

Neurobiol Aging 2013 Jun 27;34(6):1710.e7-9. Epub 2012 Dec 27.

Centre of Excellence in Neuroscience of Université de Montréal (CENUM), CHUM Research Center and the Department of Medicine, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2012.11.025DOI Listing
June 2013
16 Reads
8 Citations
5.013 Impact Factor

RLS patients can also develop compulsions on dopaminergic agonists

Authors:
Pourcher E.

Sleep Med;12(11):567-569

Sleep Medicine

View Article
March 2013
7 Reads

Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.

Mov Disord 2012 Sep 22;27(10):1230-8. Epub 2012 Aug 22.

Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (CRICM), UMR-S975, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25098DOI Listing
September 2012
25 Reads
24 Citations
5.680 Impact Factor

Influence of risperidone on balance control in young healthy individuals.

Psychopharmacology (Berl) 2012 Jul 11;222(1):59-69. Epub 2012 Jan 11.

Groupe de Recherche en Analyse du Mouvement et Ergonomie, Faculté de Médecine, Kinésiologie Université Laval, 2300 Rue de la Terrasse, Québec, QC G1V 0A6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-011-2623-7DOI Listing
July 2012
45 Reads
2 Citations
3.880 Impact Factor

Istradefylline for Parkinson's disease patients experiencing motor fluctuations: results of the KW-6002-US-018 study.

Parkinsonism Relat Disord 2012 Feb 13;18(2):178-84. Epub 2011 Oct 13.

Clinique Sainte-Anne-Laval University, 1248, Chemin Sainte-Foy, Suite # 304, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2011.09.023DOI Listing
February 2012
20 Reads
13 Citations
3.972 Impact Factor

Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.

Parkinsonism Relat Disord 2011 Sep 12;17(8):593-8. Epub 2011 Jun 12.

Department of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval, & Centre de Recherche Université Laval Robert-Giffard, Quebec City, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2011.05.012DOI Listing
September 2011
8 Reads
19 Citations
3.972 Impact Factor

Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.

Am J Geriatr Pharmacother 2011 Apr 19;9(2):133-7. Epub 2011 Apr 19.

Groupe de recherche en analyse du mouvement etergonomie, Kinesiology, Laval University, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjopharm.2011.03.002DOI Listing
April 2011
9 Reads

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial.

Lancet Neurol 2011 Mar;10(3):221-9

University of South Florida, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(11)70012-6DOI Listing
March 2011
63 Reads
29 Citations
21.900 Impact Factor

Intense dopamine innervation of the subventricular zone in Huntington's disease.

Neuroreport 2010 Dec;21(17):1074-9

Department of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNR.0b013e32834052a6DOI Listing
December 2010
9 Reads
3 Citations
1.644 Impact Factor

Emotion and object processing in Parkinson's disease.

Brain Cogn 2010 Apr 18;72(3):457-63. Epub 2010 Feb 18.

Laboratory of Cognitive Psychology and Neuroscience, Université Paris Descartes - CNRS (UMR 8189), France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bandc.2010.01.001DOI Listing
April 2010
29 Reads
2 Citations
2.480 Impact Factor

Compulsive habits in restless legs syndrome patients under dopaminergic treatment.

J Neurol Sci 2010 Mar 6;290(1-2):52-6. Epub 2009 Dec 6.

Quebec Memory and Motor Skills Disorders Research Center, Clinique Sainte-Anne, Québec, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2009.11.010DOI Listing
March 2010
26 Reads
10 Citations
2.474 Impact Factor

Affect in Parkinson's disease: validation of the two-factor approach.

J Neurol Sci 2010 Feb 10;289(1-2):27-31. Epub 2009 Sep 10.

Quebec Memory and Motor Skills Disorders Research Center, Clinique Sainte-Anne, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2009.08.048DOI Listing
February 2010
27 Reads
2.474 Impact Factor

Long-term skill proceduralization in schizophrenia.

J Int Neuropsychol Soc 2010 Jan 10;16(1):148-56. Epub 2009 Nov 10.

Cognitive Science Institute, Université du Québec à Montréal, Montreal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1355617709991123DOI Listing
January 2010
59 Reads
1 Citation
2.963 Impact Factor

The fate of the large striatal interneurons expressing calretinin in Huntington's disease.

Neurosci Res 2008 Dec 30;62(4):216-24. Epub 2008 Aug 30.

Centre de recherche Université Laval Robert-Giffard 2601, Chemin de la Canardière, Local F-6500 Beauport, Québec, Canada, G1J 2G3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neures.2008.08.007DOI Listing
December 2008
3 Reads
13 Citations
1.940 Impact Factor

Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.

J Int Neuropsychol Soc 2008 Jan;14(1):110-8

Cognitive Science Institute, Université du Québec à Montréal, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1355617708080090DOI Listing
January 2008
31 Reads
1 Citation
2.963 Impact Factor

LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.

Can J Neurol Sci 2007 Aug;34(3):333-5

Faculty of Medicine, Laval University, Department of Neurological Sciences, CHAUQ-Enfant Jésus, Quebec City, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0317167100006776DOI Listing
August 2007
9 Reads
1 Citation
1.600 Impact Factor

Intact encoding, impaired consolidation in procedural learning in Parkinson's disease.

Exp Brain Res 2007 Jun 6;179(4):703-8. Epub 2007 Feb 6.

Cognitive Neuroscience Center, Université du Québec à Montréal and Laboratoire Psychologie et Neurosciences Cognitives, CNRS-Paris Descartes, Stn. Centre-Ville, PB 8888, Montréal, QC, H3C 3P8 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00221-006-0827-6DOI Listing
June 2007
8 Reads
7 Citations
2.040 Impact Factor

The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.

Schizophr Res 2005 Dec 12;80(1):99-106. Epub 2005 Sep 12.

Cognitive Neuroscience Center, Department of Psychology, Université du Québec à Montréal, P.B. 8888, Stn. Centre-Ville, Montreal, Qc, Canada, H3C 3P8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2005.07.026DOI Listing
December 2005
35 Reads
2 Citations
3.923 Impact Factor

A dissociation between real and simulated movements in Parkinson's disease.

Neuroreport 2004 Jun;15(9):1489-92

Cognitive Neuroscience Center, Université du Québec à Montréal, PB. 8888, Stn. Centre-Ville, Montreal, Qc. H3C 3P8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.wnr.0000132429.68206.48DOI Listing
June 2004
16 Reads
4 Citations
1.644 Impact Factor

Followers